Jiangsu Canopus Wisdom Medical Technology Stock Forum

The company's low P/E ratio reflects poor earnings and the expectation of continued decline. Despite market growth projections of 42% next year, the company's P/E could fall further if profitability doesn't improve. Investor sentiment is low, with the share price unlikely to move significantly in the near future.